168 related articles for article (PubMed ID: 38394550)
1. The role of botulinum neurotoxin BoNT-A in the management of oily skin and acne vulgaris: A comprehensive review.
Dayel SB; Hussein RS; Gafar HH
Medicine (Baltimore); 2024 Feb; 103(8):e37208. PubMed ID: 38394550
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.
Shuo L; Ting Y; KeLun W; Rui Z; Rui Z; Hang W
J Cosmet Dermatol; 2019 Apr; 18(2):451-457. PubMed ID: 30697928
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism.
Rho NK; Gil YC
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822601
[TBL] [Abstract][Full Text] [Related]
4. The clinical efficacy of a new emulsion for acne and conspicuous facial pore amelioration.
Yang F; Wang H; Guo M; Zhou Z
J Cosmet Dermatol; 2024 Mar; 23(3):958-963. PubMed ID: 38140770
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of the efficacy and safety of a clay mask in oily and acne skin.
Zhang X; Zhang Z; Tao H; He X; Hsu K; Wang W; Fang X; Steel A
Skin Res Technol; 2023 Nov; 29(11):e13513. PubMed ID: 38009030
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis.
Brami-Cherrier K; Chernavsky A; You H; Grando SA; Brideau-Andersen A; Sondergaard B
Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287976
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo study of the efficacy of a new sebum control essence.
Wei J; Ma X; Chen M; Pan S; Pang Y
J Cosmet Dermatol; 2023 Sep; 22(9):2605-2611. PubMed ID: 37114429
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of botulinum toxin type A (BTX-A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post-acne.
Shirshakova M; Morozova E; Sokolova D; Pervykh S; Smirnova L
Int J Dermatol; 2021 Oct; 60(10):1232-1241. PubMed ID: 33937981
[TBL] [Abstract][Full Text] [Related]
9. Oily sensitive skin: A review of management options.
Hong JY; Park SJ; Seo SJ; Park KY
J Cosmet Dermatol; 2020 May; 19(5):1016-1020. PubMed ID: 32112510
[TBL] [Abstract][Full Text] [Related]
10. New Uses of AbobotulinumtoxinA in Aesthetics.
Schlessinger J; Gilbert E; Cohen JL; Kaufman J
Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
[TBL] [Abstract][Full Text] [Related]
11. Microneedle delivery of botulinum toxin type A combined with hyaluronic acid for the synergetic management of multiple sternal keloids with oily skin: A retrospective clinical investigation.
Zhang S; Peng Y; Fan H; Zhang Y; Min P
J Cosmet Dermatol; 2022 Nov; 21(11):5601-5609. PubMed ID: 35796638
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and comparison of the efficacy and safety of cross-linked and non-cross-linked hyaluronic acid in combination with botulinum toxin type A in the treatment of atrophic acne scars: A double-blind randomized clinical trial.
Behrangi E; Dehghani A; Sheikhzadeh F; Goodarzi A; Roohaninasab M
Skin Res Technol; 2024 Jan; 30(1):e13541. PubMed ID: 38174839
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Bibliographic Review Concerning the Efficacy of Organic Acids for Chemical Peels Treating Acne Vulgaris.
Măgerușan ȘE; Hancu G; Rusu A
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894698
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.
Rose AE; Goldberg DJ
Dermatol Surg; 2013 Mar; 39(3 Pt 1):443-8. PubMed ID: 23293895
[TBL] [Abstract][Full Text] [Related]
15. Patient experiences with oily skin: the qualitative development of content for two new patient reported outcome questionnaires.
Arbuckle R; Atkinson MJ; Clark M; Abetz L; Lohs J; Kuhagen I; Harness J; Draelos Z; Thiboutot D; Blume-Peytavi U; Copley-Merriman K
Health Qual Life Outcomes; 2008 Oct; 6():80. PubMed ID: 18925946
[TBL] [Abstract][Full Text] [Related]
16. Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now?
Reddy AG; Dick BP; Natale C; Akula KP; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):320-330. PubMed ID: 32641225
[TBL] [Abstract][Full Text] [Related]
17. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne.
Draelos ZD
Cutis; 2006 Jul; 78(1 Suppl):34-40. PubMed ID: 16910029
[TBL] [Abstract][Full Text] [Related]
18. Non-cosmetic dermatological uses of botulinum neurotoxin.
Forbat E; Ali FR; Al-Niaimi F
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2023-2029. PubMed ID: 27421250
[TBL] [Abstract][Full Text] [Related]
19. Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.
Tanghetti EA; Zeichner JA; Gold M; Sadick N; Cook-Bolden FE; Kircik LH; Stein Gold L; Weiss J; Tyring SK; Del Rosso JQ; Guenin E
J Dermatolog Treat; 2023 Dec; 34(1):2147391. PubMed ID: 36382987
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris.
Orringer JS; Kang S; Maier L; Johnson TM; Sachs DL; Karimipour DJ; Helfrich YR; Hamilton T; Voorhees JJ
J Am Acad Dermatol; 2007 Mar; 56(3):432-8. PubMed ID: 17239987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
